Keine Ankündigung bisher.


  • Filter
  • Zeit
  • Anzeigen
Alles löschen
neue Beiträge

  • GTx

    mal ratzfatz 90% ins minus, der laden war mal ne halbe milliarde wert...

    GTx Inc. stock drops 94% after phase 2 trial failure

    GTx Inc. GTXI, -92.01% stock dropped as much as 94% in Friday [WIKI]premarket[/WIKI] trade after the company said that enobosarm, its therapy intended for post-menopausal women with stress urinary incontinence, did not meet the primary endpoint in a phase 2 clinical trial. The double-blind and placebo-controlled trial had enrolled nearly 500 women. Enobosarm is the company's main product candidate, which it has been developing in stress urinary incontinence as well as breast cancer. GTx is also developing a preclinical candidate for prostate cancer. Company shares have surged nearly 26% to $23.29 over the last three months


    jetzt auf ->

    finviz Stock Screener

    Bitcoin Trading